Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of intraventricular hemorrhage with Actilyse
2008-008215-25Phase 2Completed
- Sponsor
- Walter Fischer
- Start
- Jan 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tissue-plasminogen activator in subarachnoid hemorrhage (SAH), Intraventricular hemorrhage (IVH), cerebral vasospasm and 1 more, sponsored by Walter Fischer. Primary endpoint: Delayed cerebral ischemia after subarachnoid hemorrhage. Started Jan 2009; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
subarachnoid hemorrhage (SAH)Intraventricular hemorrhage (IVH)cerebral vasospasmdelayed cerebral ischemia (DCI)
Beyond the preview
Go deeper on 2008-008215-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008215-25.